Pharmacists from Japan experience developed in Siberia, a cure for cancer – RIA Novosti

NOVOSIBIRSK, July 7 – RIA Novosti. The specialists of Japanese pharmaceutical company Takeda in conjunction with scientists from the Institute of Chemical Biology and Fundamental Medicine of the Russian Academy of Sciences will be working on a promising new drug for the treatment of cancer, according to the website of the Russian representation of Japanese the company.

“project will bring together” Shonan “, the largest research and development center of the company Takeda in Japan and the Institute of Chemical Biology and Fundamental Medicine of the SB RAS within the framework of research on the early stages of development Created by one of the institute promising drugs in oncology and immunology, “- said in a statement.

It is expected that experts will assess the therapeutic potential of the drug developed in Russia in the center of biological models in Japan and develop a new treatment strategy drug. Cooperation will provide an opportunity to better understand the mechanism of action of the drug, and can also be an opportunity to develop a potential new therapeutic approach in oncology and immunology, said in a statement.

In turn, the director of the Institute of Chemical Biology and Fundamental Medicine, said Valentin Vlasov, Such international partnerships are an important mechanism in the development of promising drugs is especially important in the treatment of cancer, viral diseases and immunodeficiencies.

“Patients need effective solutions, which do not yet exist. In developing this project in partnership with” Takeda “we get the opportunity to spend the planned study in the short term and to use the most modern methodological approaches and technologies “, – said Vlasov, noting that preliminary studies give hope to create an innovative drug for the treatment of cancer and possibly viral diseases.

The Cooperation Agreement between Takeda and the Siberian Branch of the Russian Academy of Sciences was signed February 18, 2014 in Japan. To determine the areas of partnership and the choice of specific projects to be implemented within its framework, Steering Committee was established. Takeda is one of the world leaders in the pharmaceutical field.